DUPILUMAB — all Canadian products
5 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DUPILUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02470365 | DUPIXENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | DUPILUMAB 300 MG | Marketed | |
| 02492504 | DUPIXENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | DUPILUMAB 200 MG | Marketed | |
| 02510049 | DUPIXENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | DUPILUMAB 300 MG | Marketed | |
| 02524252 | DUPIXENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | DUPILUMAB 200 MG | Marketed | |
| 02526190 | DUPIXENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | DUPILUMAB 100 MG | Cancelled Pre Market |
Browse other molecules: